AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Aug 1, 2024
35599_dirs_2024-08-01_f689d42c-28e4-49e7-b057-c428d977e9a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-07-31
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-31 | Common shares | A | 2431 | — | Acquired | 189902 | Direct |
| 2024-08-01 | Common shares | S | 2431 | $6.255 | Disposed | 187471 | Direct |
Footnotes
F1: Represents release of restriction from shares awarded 3-31-2023
F2: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20